Eli Lilly and Company
AT ˙ WBAG ˙ US5324571083
€ 981,00 ↑47.20 (5.05%)
2026-06-04
PREÇO DA AÇÃO
SecurityAT:LLYC / Eli Lilly and Company
InstitutionEquitable Trust Co
Latest Disclosed Ownership9,962 shares
Latest Disclosed Value $ 9,162,749
Equitable Trust Co reports 3.53% decrease in ownership of LLYC / Eli Lilly and Company

On April 30, 2026 - Equitable Trust Co filed a 13F-HR form disclosing ownership of 9,962 shares of Eli Lilly and Company (AT:LLYC) valued at $7,884,923 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 10,327 shares of Eli Lilly and Company. This represents a change in shares of -3.53% during the quarter. The current value of the position is $9,772,722 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-30 2026-03-31 13F Eli Lilly Com 532457108 9,962 -365 -3.53 9,163 -17.44 0.2494
2026-02-02 2025-12-31 13F Eli Lilly Com 532457108 10,327 2,325 29.06 11,098 81.79 0.4955
2025-11-10 2025-09-30 13F Eli Lilly Com 532457108 8,002 -309 -3.72 6,106 -5.76 0.2807
2025-07-23 2025-06-30 13F Eli Lilly Com 532457108 8,311 -112 -1.33 6,479 -6.87 0.3228
2025-04-25 2025-03-31 13F Eli Lilly Com 532457108 8,423 -134 -1.57 6,957 5.30 0.3854
2025-01-28 2024-12-31 13F Eli Lilly Com 532457108 8,557 17 0.20 6,606 -12.68 0.3687
2024-10-29 2024-09-30 13F Eli Lilly Com 532457108 8,540 26 0.31 7,566 -1.86 0.4855
2024-07-31 2024-06-30 13F Eli Lilly Com 532457108 8,514 1 0.01 7,708 16.40 0.5302
2024-04-24 2024-03-31 13F Eli Lilly Com 532457108 8,513 -327 -3.70 6,623 28.51 0.4594
2024-01-25 2023-12-31 13F Eli Lilly Com 532457108 8,840 -60 -0.67 5,153 7.80 0.3874
2023-11-06 2023-09-30 13F Eli Lilly Com 532457108 8,900 175 2.01 4,780 16.84 0.3952
2023-08-08 2023-06-30 13F Eli Lilly Com 532457108 8,725 -215 -2.40 4,092 33.26 0.3129
2023-05-02 2023-03-31 13F Eli Lilly Com 532457108 8,940 156 1.78 3,070 -4.45 0.2418
2023-02-17 2022-12-31 13F Eli Lilly Com 532457108 8,784 -1,079 -10.94 3,214 0.75 0.2532
2022-10-31 2022-09-30 13F Eli Lilly Com 532457108 9,863 -933 -8.64 3,189 -8.89 0.2658
2022-07-15 2022-06-30 13F Eli Lilly Com 532457108 10,796 -605 -5.31 3,500 7.20 0.2607
2022-05-06 2022-03-31 13F Eli Lilly Com 532457108 11,401 -268 -2.30 3,265 1.30 0.2098
2022-01-31 2021-12-31 13F Eli Lilly Com 532457108 11,669 -87 -0.74 3,223 18.67 0.1991
2021-10-26 2021-09-30 13F Lilly Eli Com 532457108 11,756 -659 -5.31 2,716 -4.70 0.1734
2021-08-03 2021-06-30 13F Lilly Eli Com 532457108 12,415 308 2.54 2,850 25.99 0.1828
2021-05-14 2021-03-31 13F Lilly Eli Com 532457108 12,107 2,476 25.71 2,262 39.03 0.1685
2021-02-12 2020-12-31 13F Lilly Eli Com 532457108 9,631 0 0.00 1,627 14.10 0.1208
2020-11-13 2020-09-30 13F Lilly Eli Com 532457108 9,631 0 0.00 1,426 -9.80 0.1214
2020-08-18 2020-06-30 13F Lilly Eli Com 532457108 9,631 -238 -2.41 1,581 15.49 0.1454
2020-05-21 2020-03-31 13F Lilly Eli Com 532457108 9,869 0 0.00 1,369 5.55 0.1505
2020-02-18 2019-12-31 13F Lilly Eli Com 532457108 9,869 -1,370 -12.19 1,297 3.26 0.1267
2019-11-19 2019-09-30 13F Lilly Eli Com 532457108 11,239 570 5.34 1,256 6.26 0.1323
2019-08-16 2019-06-30 13F Lilly Eli Com 532457108 10,669 0 0.00 1,182 -14.66 0.1254
2019-05-15 2019-03-31 13F Lilly Eli Com 532457108 10,669 -52 -0.49 1,385 11.69 0.1600
2019-02-22 2018-12-31 13F Lilly Eli Com 532457108 10,721 0 0.00 1,240 7.83 0.1641
2018-11-15 2018-09-30 13F Lilly Eli Com 532457108 10,721 -100 -0.92 1,150 24.59 0.1340
2018-08-14 2018-06-30 13F Lilly Eli Com 532457108 10,821 10,821 923 0.1169
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.